Skip to main content
Supplement ScienceSupplementScience

Types of Echinacea: Forms & Bioavailability

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Forms Comparison

FormBioavailabilityBest For
Standardized Extract (Capsules)ModerateConsistent dosing — standardized to alkamide or chicoric acid content
Fresh-Pressed Juice (Echinaforce)HighBest-studied preparation — fresh E. purpurea aerial parts preserved as tincture
Dried Root ExtractModerateTraditional use — E. angustifolia root is higher in alkamides
Echinacea TeaLow-ModerateMild daily support — pleasant taste but lower active compound concentration

Standardized Extract (Capsules)

Bioavailability: Moderate. Best for: Consistent dosing — standardized to alkamide or chicoric acid content.

Fresh-Pressed Juice (Echinaforce)

Bioavailability: High. Best for: Best-studied preparation — fresh E. purpurea aerial parts preserved as tincture.

Dried Root Extract

Bioavailability: Moderate. Best for: Traditional use — E. angustifolia root is higher in alkamides.

Echinacea Tea

Bioavailability: Low-Moderate. Best for: Mild daily support — pleasant taste but lower active compound concentration.

References

  1. Meta-analysisShah SA, Sander S, White CM, Rinaldi M, Coleman CI (2007). Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. The Lancet Infectious Diseases. DOI PubMed
  2. Meta-analysisKarsch-Volk M, Barrett B, Kiefer D, Bauer R, Ardjomand-Woelkart K, Linde K (2014). Echinacea for preventing and treating the common cold. Cochrane Database of Systematic Reviews. DOI PubMed
  3. Meta-analysisPham TP, Vu TM, Doan PM, Nguyen TT, et al. (2025). Efficacy and safety of Echinacea purpurea in treating upper respiratory infections and complications of otitis media in children: Systematic review and meta-analysis.. Clinical nutrition ESPEN. DOI PubMed
  4. Meta-analysisDeccy S, Bartkowiak C, Rodricks N, Paultre K (2024). Echinacea Supplementation Does Not Impact Aerobic Capacity and Erythropoiesis in Athletes: A Meta-Analysis.. Nutrients. DOI PubMed
  5. Meta-analysisDavid S, Cunningham R (2019). Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis.. Complementary therapies in medicine. DOI PubMed
  6. Schoop R, Klein P, Suter A, Johnston SL (2006). Echinacea in the prevention of induced rhinovirus colds: a meta-analysis.. Clinical therapeutics. DOI PubMed
  7. Linde K, Barrett B, Wölkart K, Bauer R, et al. (2006). Echinacea for preventing and treating the common cold.. The Cochrane database of systematic reviews. DOI PubMed
Show 5 more references
  1. Gillespie EL, Coleman CI (2006). The effect of Echinacea on upper respiratory infection symptom severity and quality of life.. Connecticut medicine. PubMed
  2. Ernst E (2002). The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava.. Annals of internal medicine. DOI PubMed
  3. Huntley AL, Thompson Coon J, Ernst E (2005). The safety of herbal medicinal products derived from Echinacea species: a systematic review.. Drug safety. DOI PubMed
  4. Basch E, Ulbricht C, Basch S, Dalton S, et al. (2005). An evidence-based systemic review Echinacea E. angustifolia DC, E. pallida, E. purpurea by the Natural Standard Research Collaboration.. Journal of herbal pharmacotherapy. PubMed
  5. Melchart D, Linde K, Fischer P, Kaesmayr J (2000). Echinacea for preventing and treating the common cold.. The Cochrane database of systematic reviews. DOI PubMed